SCHEMBL23155156

SCHEMBL23155156

c1ccc2c(c1)-c1cccc3c1-c1cc(N(c4cccc5ccccc45)c4cccc5ccccc45)ccc1-c1cccc-3c1-2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNMT1 P26358 1/20 0.40
▸ SIGMAR1 Q99720 7/20 0.37
▸ ANPEP P15144 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ TSHR P16473 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ CES1 P23141 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ DHFR P00374 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ ALPL P05186 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23155179 0.93 SIGMAR1 (0.38) DNMT1SIGMAR1ANPEPALDH1A1TSHR
SCHEMBL23155327 0.92 DNMT1 (0.35) DNMT1SIGMAR1ANPEPALDH1A1TSHR
SCHEMBL23155155 0.92 ALDH1A1 (0.36) DNMT1SIGMAR1ANPEPALDH1A1TSHR
SCHEMBL23155157 0.91 DNMT1 (0.40) DNMT1SIGMAR1ANPEPALDH1A1TSHR
SCHEMBL20842755 0.90 SIGMAR1 (0.41) DNMT1SIGMAR1ALDH1A1TSHRMAPK1
SCHEMBL23155376 0.89 DNMT1 (0.35) DNMT1SIGMAR1ANPEPALDH1A1TSHR
SCHEMBL23155312 0.89 DNMT1 (0.35) DNMT1SIGMAR1ANPEPALDH1A1TSHR
SCHEMBL23155248 0.89 MCL1 (0.37) DNMT1SIGMAR1C5AR1MCL1ACMSD
SCHEMBL23155164 0.88 HDAC4 (0.36) DNMT1SIGMAR1ANPEPALDH1A1TSHR
SCHEMBL23155154 0.88 SIGMAR1 (0.35) DNMT1SIGMAR1ANPEPALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-28 — — US disclosed
EP-3799144-B1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2022-06-01 — — EP disclosed
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same CRY1, SMCHD1, CXCR1 DNMT1 1952/4885SIGMAR1 1167/4885ANPEP 4193/4885
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME CRY1, SMCHD1, CXCR1 DNMT1 1952/4885SIGMAR1 1167/4885ANPEP 4193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback